Results 31 to 40 of about 44,137,376 (192)

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Weight Loss and Engagement in a Tirzepatide-Supported Digital Obesity Program: A Four-Arm Patient-Blinded Retrospective Cohort Study

open access: yesTelemedicine Reports
Background: Obesity is arguably the greatest public health concern in the present day. Digital weight-loss services (DWLSs) that utilize modern medications have demonstrated potential in increasing access to effective obesity treatment.
Louis Talay   +3 more
doaj   +1 more source

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

open access: yesMolecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir   +9 more
wiley   +1 more source

Why People with Overweight and Obesity Are Seeking Care Through Digital Obesity Services: A Qualitative Analysis of Patients from Australia’s Largest Digital Obesity Provider

open access: yesTelemedicine Reports
Background: Increasingly large numbers of people with overweight and obesity (PWOO) are seeking care through digital services. Digital weight-loss service (DWLS) advocates claim that this is due to the modality’s mitigation of obesity care access ...
Louis Talay, Matt Vickers, Sarah Loftus
doaj   +1 more source

Cross-National Outcomes of a Digital Weight Loss Intervention in the United States, Canada, United Kingdom and Ireland, and Australia and New Zealand: A Retrospective Analysis

open access: yesFrontiers in Public Health, 2021
Mobile health (mHealth) interventions are ubiquitous and effective treatment options for obesity. There is a widespread assumption that the mHealth interventions will be equally effective in other locations.
Qiuchen Yang   +7 more
doaj   +1 more source

An outer membrane vesicle‐associated two‐track model for enterotoxigenic Bacteroides fragilis oncogenesis

open access: yesMolecular Oncology, EarlyView.
Enterotoxigenic Bacteroides fragilis is a gut bacterium linked to bowel cancer. We propose that its toxin acts along two routes: at the cell surface, cutting the adhesion protein E‐cadherin and triggering inflammation; and inside the cell, delivered by bacterial vesicles, switching on NOD1 and cancer stem cell programs.
Kangchan Choi   +2 more
wiley   +1 more source

Words matter: a qualitative investigation of which weight status terms are acceptable and motivate weight loss when used by health professionals [PDF]

open access: yes, 2011
<p><b>Background:</b> Obesity prevalence is increasing, which is a major public health concern due to increased risks of associated morbidity.
Benzeval, Michaela   +26 more
core   +2 more sources

Effectiveness and Side Effect Incidence in a Real-World Digital Weight-Loss Service Using Compounded Semaglutide: A Retrospective Comparative Study

open access: yesObesities
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were originally developed in the late 1980s as a class of antidiabetic medication. However, research over the past decade has found them to be a safe and effective weight-loss agent, which has led to ...
Louis Talay, Matt Vickers
doaj   +1 more source

Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease

open access: yesFEBS Open Bio, EarlyView.
Repair of neuronal DNA damage in Alzheimer's disease by KCL‐286. (A) Amyloid‐β oligomers and plaques impair neuronal DNA repair pathways, leading to DNA double‐strand breaks and glial activation. (B) KCL‐286 activates RARβ/RXR signalling via retinoic acid response elements (RAREs), associated with increased BRCA1 expression, enhanced DNA repair and ...
Natasha Hill   +6 more
wiley   +1 more source

FEASIBILITY OF A CAMPAIGN INTERVENTION COMPARED TO A STANDARD BEHAVIORAL WEIGHT LOSS INTERVENTION IN OVERWEIGHT AND OBESE ADULTS [PDF]

open access: yes, 2013
Overweight and obesity are a significant public health concern. Behavioral treatment is considered the first line of intervention for individuals attempting to lose weight.
Garcia, David
core  

Home - About - Disclaimer - Privacy